Received May 28, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | UNK | — |
body aches; Chills; Fever; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of general body pain in a patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced general body pain (Verbatim: body aches), chills (Verbatim: Chills) and fever (Verbatim: Fever). The outcome of the general body pain, chills and fever were not reported. It was unknown if the reporter considered the general body pain, chills and fever to be related to Shingrix. Additional Information: GSK Receipt Date: 24-MAY-2026 This case was reported by a consumer via interactive digital media. After getting the vaccine patient had body aches, fever and chills. And asked if can get the second shot. The batch number was not provided and unable to contact the reporter.